Phoenix Tissue Repair, Inc

Phoenix Tissue Repair is advancing a novel treatment for Dystrophic Epidermolysis Bullosa, a rare skin disease resulting from a defieincy of human collagen.

[Phoenix Tissue Repair, Inc @TissueInc]

This holiday season, we thank those who are dedicated to improving the lives of people living with EB and reflect on our own mission to develop a safe & effective protein replacement therapy for those with RDEB. Have a safe, happy holiday season! #EpidermolysisBullosa #HealEB

[Phoenix Tissue Repair, Inc @TissueInc]

Phoenix Tissue Repair is a proud sponsor of EB Research Partnership's Venture Into Cures, a virtual event led by EBRP Co-Founders Jill & Eddie Vedder on November 18 at 8pm EST. #EBAwareness by tuning in on 11/18 at https://t.co/LuNFIEl2eQ.

[Phoenix Tissue Repair, Inc @TissueInc]

In honor of the 500,000 children and adults living with Epidermolysis Bullosa and their families, we’re working hard to develop a systemic, protein replacement treatment for the recessive form of DEB. @debraOfAmerica #EBAwarenessWeek #HealEB #EBWeek

[Phoenix Tissue Repair, Inc @TissueInc]

Check out the poster presentation at the annual @GeneticsSociety Meeting #ASHG20, featuring interim data from our ongoing Ph 1/2 study of PTR-01 for patients with RDEB. The poster is now available on our website: https://t.co/ZZk8UtbEWm

[Phoenix Tissue Repair, Inc @TissueInc]

Today we announced that the first patient has been dosed in our Phase 2 study of PTR-01 for patients with RDEB – a genetic disorder in which there are no effective treatments currently available. Details about PTR-01 and the study here: https://t.co/obZVgaew98

[Phoenix Tissue Repair, Inc @TissueInc]

We’re passionate about developing a safe and effective therapy that targets the root cause of RDEB and treats the symptoms that matter most to patients. We’re looking forward to the live Q&A tomorrow!

[debra of America @debraOfAmerica]

Join us next Tuesday at 3pm ET for a LIVE Conversation with Phoenix Tissue Repair! The company is advancing an investigational therapy known as PTR-01 for the treatment of RDEB. Learn about this therapy & get your Qs answered by the experts! Register: https://t.co/PEn46rR0zD

[Phoenix Tissue Repair, Inc @TissueInc]

Today we announced updates to our ongoing Phase 1/2 study of PTR-01 for the treatment of a rare genetic skin disorder called recessive dystrophic epidermolysis bullosa (RDEB) and we’ve added new leadership. Read more about this news here: https://t.co/ddXWVu757C

[debra of America @debraOfAmerica]

The 20th Annual #debraBenefit was a night to remember! Thank you to everyone who joined us on October 25 to kick off National #EBweek. For photos from the evening, please visit: https://t.co/DF10aDSWKB

[Phoenix Tissue Repair, Inc @TissueInc]

Welcome to the Phoenix Tissue Repair twitter page! We're glad you found us! Follow us for updates on our search to find a treatment for DEB.